Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Operating Leases (2020 - 2025)

Historic Operating Leases for Precision Biosciences (DTIL) over the last 6 years, with Q3 2025 value amounting to $6.8 million.

  • Precision Biosciences' Operating Leases changed 0.0% to $6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.8 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $6.4 million for FY2024, which is 1707.89% down from last year.
  • According to the latest figures from Q3 2025, Precision Biosciences' Operating Leases is $6.8 million, which was down 0.0% from $7.1 million recorded in Q2 2025.
  • Precision Biosciences' Operating Leases' 5-year high stood at $8.1 million during Q1 2021, with a 5-year trough of $1.1 million in Q4 2022.
  • Its 5-year average for Operating Leases is $5.6 million, with a median of $6.6 million in 2024.
  • As far as peak fluctuations go, Precision Biosciences' Operating Leases plummeted by 7799.71% in 2022, and later surged by 62927.29% in 2023.
  • Over the past 5 years, Precision Biosciences' Operating Leases (Quarter) stood at $4.8 million in 2021, then tumbled by 78.0% to $1.1 million in 2022, then surged by 629.27% to $7.7 million in 2023, then decreased by 17.08% to $6.4 million in 2024, then grew by 5.47% to $6.8 million in 2025.
  • Its Operating Leases was $6.8 million in Q3 2025, compared to $7.1 million in Q2 2025 and $6.0 million in Q1 2025.